US BANCORP \DE\ - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 160 filers reported holding NEVRO CORP in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2023$53,912
+176.5%
2,805
+265.7%
0.00%
Q2 2023$19,497
+10.3%
767
+56.9%
0.00%
Q1 2023$17,677
+4.0%
489
+36.6%
0.00%
Q3 2022$17,000
-22.7%
358
-29.4%
0.00%
Q2 2022$22,000
+144.4%
507
+305.6%
0.00%
Q1 2022$9,000
-40.0%
125
-35.9%
0.00%
Q4 2021$15,000
+1400.0%
195
+3150.0%
0.00%
Q4 2020$1,0006
+500.0%
0.00%
Q2 2020$010.0%0.00%
Q1 2020$0
-100.0%
1
-96.0%
0.00%
Q4 2019$3,000
+50.0%
250.0%0.00%
Q3 2019$2,000
-83.3%
25
-86.6%
0.00%
Q2 2019$12,000
-61.3%
186
-63.3%
0.00%
Q1 2019$31,000
-3.1%
507
-38.5%
0.00%
Q4 2018$32,000
-86.2%
825
-79.8%
0.00%
-100.0%
Q3 2018$232,000
-48.1%
4,080
-27.2%
0.00%0.0%
Q2 2018$447,000
-0.4%
5,601
+8.2%
0.00%0.0%
Q1 2018$449,000
+43.5%
5,176
+14.3%
0.00%0.0%
Q4 2017$313,000
-12.8%
4,530
+14.7%
0.00%0.0%
Q3 2017$359,000
+85.1%
3,951
+51.5%
0.00%0.0%
Q2 2017$194,000
+304.2%
2,608
+412.4%
0.00%
Q1 2017$48,000
+220.0%
509
+147.1%
0.00%
Q4 2016$15,000
-28.6%
206
+2.5%
0.00%
Q3 2016$21,000
-64.4%
201
-75.1%
0.00%
Q2 2016$59,000
+353.8%
806
+258.2%
0.00%
Q1 2016$13,000
-13.3%
2250.0%0.00%
Q4 2015$15,0002250.00%
Other shareholders
NEVRO CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Tiger Eye Capital LLC 239,122$41,392,0008.25%
Integral Health Asset Management, LLC 88,000$15,233,0004.53%
Iron Triangle Partners LP 168,761$29,213,0003.79%
Eos Focused Equity Management, L.P. 14,002$2,424,0002.37%
PFM Health Sciences, LP 311,940$53,997,0001.90%
Perceptive Advisors 977,565$169,217,0001.82%
Rock Springs Capital Management LP 395,000$68,375,0001.45%
Lisanti Capital Growth, LLC 54,302$9,400,0001.30%
HealthCor Management, L.P. 156,046$27,012,0001.04%
FRED ALGER MANAGEMENT, LLC 2,136,612$369,848,0000.96%
View complete list of NEVRO CORP shareholders